您的购物车当前为空
LQZ-7I 能口服有效地抑制异种移植肿瘤生长并诱导肿瘤中生存素的损失。它是一种靶向生存素的抑制剂,抑制生存素二聚化。


为众多的药物研发团队赋能,
让新药发现更简单!
LQZ-7I 能口服有效地抑制异种移植肿瘤生长并诱导肿瘤中生存素的损失。它是一种靶向生存素的抑制剂,抑制生存素二聚化。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 292 | In stock | |
| 5 mg | ¥ 493 | In stock | |
| 10 mg | ¥ 828 | In stock | |
| 25 mg | ¥ 1,660 | In stock | |
| 50 mg | ¥ 2,660 | In stock | |
| 100 mg | ¥ 3,930 | In stock | |
| 500 mg | ¥ 8,790 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 547 | In stock |
LQZ-7I 相关产品
| 产品描述 | LQZ-7I is an inhibitor of surviving-targeting. It orally effectively inhibits xenograft tumor growth and induces survivin loss in tumors |
| 分子量 | 348.35 |
| 分子式 | C20H14F2N4 |
| CAS No. | 195822-23-2 |
| Smiles | Fc1ccc(Nc2nc3ccccc3nc2Nc2ccc(F)cc2)cc1 |
| 密度 | 1.390 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 120 mg/mL (344.48 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容